Loading news...
An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.
8 Knots Management LLC bought a new stake in shares of Addus HomeCare Corporation (NASDAQ: ADUS) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 51,491 shares of the company's stock, valued at approximately $6,075,000. Addus HomeCare accounts
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences: Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026. Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer will participate in a virtual presentation at 9:20 a.m. Eastern Time / 8:20 a.m. Central Time on Mon.
Addus HomeCare Corporation (NASDAQ: ADUS - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 1,148,513 shares, a growth of 23.5% from the January 29th total of 929,786 shares. Based on an average trading volume of 252,301 shares,
Addus HomeCare (NASDAQ: ADUS - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Volatility and Risk Addus HomeCare has a beta
Addus HomeCare Corporation (ADUS) Q4 2025 Earnings Call Transcript
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that management will participate in the Raymond James & Associates 47th Annual Institutional Investors Conference, which takes place March 1 – 4, 2026, in Orlando, Florida. In connection with the conference, there will be a live broadcast and replay of the Company's presentation available under the Investor Relations section of the Company's website, www.addus.com, st.
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Addus HomeCare (ADUS) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.38 per share a year ago.
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow f.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Addus HomeCare (ADUS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Public Sector Pension Investment Board increased its position in shares of Addus HomeCare Corporation (NASDAQ: ADUS) by 14.4% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 70,827 shares of the company's stock after buying an additional 8,893 shares during the quarter.
Addus HomeCare Corporation (NASDAQ: ADUS - Get Free Report) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 929,786 shares, an increase of 20.1% from the January 15th total of 774,495 shares. Based on an average trading volume of 224,285 shares, the days-to-cover ratio
Ceres Ventures (OTCMKTS:CEVE - Get Free Report) and Addus HomeCare (NASDAQ: ADUS - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Profitability This table compares Ceres Ventures and Addus
Addus HomeCare (ADUS) is positioned for accelerated organic growth, driven by recent reimbursement rate increases and a softening labor market in key states. ADUS's Personal Care segment, representing 72% of operating income, will benefit from improved hiring and wage competitiveness in Illinois and Texas. Hospice segment growth is robust, with 9.5% same-store patient growth and rising acuity, while the smaller Home Health segment faces headwinds from Medicare rate cuts.
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather.
LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Addus HomeCare (NASDAQ: ADUS - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, valuation, dividends, profitability and analyst recommendations. Profitability This table compares LifeStance Health
Addus HomeCare (NASDAQ: ADUS - Get Free Report) and Ceres Ventures (OTCMKTS:CEVE - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Profitability This table compares Addus HomeCare and Ceres
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).